# Radiofrequency Ablation (RFA) Versus Antiarrhythmic Drug Treatment in Paroxysmal Atrial Fibrillation

> **NCT00133211** · PHASE3 · COMPLETED · sponsor: **Danish Heart Foundation** · enrollment: 294 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **PROCEDURE:** Radiofrequency ablation

## Key facts

- **NCT ID:** NCT00133211
- **Lead sponsor:** Danish Heart Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 294 (ACTUAL)
- **Last updated:** 2015-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00133211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00133211, "Radiofrequency Ablation (RFA) Versus Antiarrhythmic Drug Treatment in Paroxysmal Atrial Fibrillation". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT00133211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*